| abstract |
The present invention relates to a new utilization of a sophorolipidic compound, pharmaceutically acceptable salts of the acid form of the sophorolipid and of the ester of the deacetelated sophorolipid acid form as therapeutically active substances in a method for the therapeutic treatment of the human or animal body, and more particularly as activator of macrophages, as fibrinolytic agent, as healing agent, as desquamation agent and as depigmentation agent. Application to the treatment of the skin. |